M. Q. Lacy

843 citations
11 papers · 554 indexed · h-index 7
  • Nephrology top 5%
    • Renal Diseases and Glomerulopathies 3
  • Hematology top 5%
    • Multiple Myeloma Research and Treatments 5
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
    • Cancer Treatment and Pharmacology 4
    • Amyloidosis: Diagnosis, Treatment, Outcomes 4
    • Protein Degradation and Inhibitors 2
    • Glycosylation and Glycoproteins Research 1
    • IgG4-Related and Inflammatory Diseases 1

M. Q. Lacy

11 papers receiving 544 citations

Peers

M. Q. Lacy
Comparison fields: 5 of 48
  • Nephrology 140
  • Hematology 189
  • Genetics 79
  • Oncology 200
  • Molecular Biology 428
Replace S. R. Hayman with:
S. R. Hayman United States
Brandt L. Esplin United States
Emancipator Sn United States
Loretta Pfannes United States
Maria Papaioannou Greece
Kinga Hosszu United States
Zonghong Shao China
John Higgins United States
Zonghong Shao China
Lise Halbwachs France
M. Q. Lacy relative to S. R. Hayman United States S. R. Hayman's profile →
Citations per field
00.5×1.5×
S. R. Hayman · 1×
Citations per year

Countries citing papers authored by M. Q. Lacy

Since Specialization
Citations

This map shows the geographic impact of M. Q. Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Q. Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Q. Lacy more than expected).

Fields of papers citing papers by M. Q. Lacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Q. Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Q. Lacy. The network helps show where M. Q. Lacy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M. Q. Lacy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Q. Lacy Line = papers co-authored together M. Q. Lacy links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 2017121
2 201675
3 201149
4 201135
5 20114
6 20103
7 20104
8 200982
9 200865
10 20086
11 1999110

About M. Q. Lacy

M. Q. Lacy is a scholar working on Hematology, Nephrology and Oncology, having authored 11 papers that have together received 554 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Renal Diseases and Glomerulopathies (3 papers), Protein Degradation and Inhibitors (2 papers), Glycosylation and Glycoproteins Research (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper) and IgG4-Related and Inflammatory Diseases (1 paper). The work is most often cited by research in Nephrology (140 citations), Hematology (189 citations) and Genetics (79 citations). M. Q. Lacy has collaborated with scholars based in United States. Frequent co-authors include Angela Dispenzieri, Morie A. Gertz, S. R. Hayman, Stephen J. Russell, Francis K. Buadi, Nelson Leung, David Dingli, S. Vincent Rajkumar, Shaji Kumar and John A. Lust. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Haematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026